Association between amiodarone use and risk of cataract: a population-based active-comparator study
Postgraduate Medical Journal · 2024
DOI: 10.1093/postmj/qgae034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, 2024. Verfasst von Sheng-Yin To und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan. Hauptthemen laut MEDLINE: Amiodarone, Cataract, Anti-Arrhythmia Agents. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Background
Despite previous concerns about ocular side effects related to amiodarone, the relationship between amiodarone and cataract remains uncertain. Therefore, this study aimed to assess the potential association between amiodarone use and the subsequent risk of cataract, taking into account potential confounders.
Methods
This population-based, active comparator-controlled cohort study utilized the data from the Taiwan National Health Insurance program and involved adults over 40 years old between 2001 and 2013. We analyzed 12 055 new amiodarone users and contrasted them with a propafenone user cohort. The primary outcome was the incidence of cataract. Inverse-probability treatment-weighting (IPTW) was further used to eliminate the potential confounding effects, and Cox proportional-hazard regression analyses were performed to calculate the risk of cataract. Serial subgroup analyses were also performed.
Results
In the main analysis, amiodarone users did not exhibit a significant causal relationship in both full cohort [adjusted hazard ratio (aHR): 0.994, 95% confidence interval (CI): 0.913–1.082] and IPTW cohort (IPTW-aHR 0.977, 95% CI: 0.900–1.060). Furthermore, it is important to highlight a significantly reduced risk of cataract among patients with heart failure (IPTW-aHR 0.708, 95% CI: 0.554–0.905) and during the 2-year follow-up period (IPTW-aHR 0.889, 95% CI: 0.794–0.996), implying potential advantages linked to the use of amiodarone.
Conclusions
The study found no increased risk of cataract with amiodarone, one of the most frequently used antiarrhythmic medications, compared to the use of propafenone. Future research is recommended to explore potential mechanisms and their implications for clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.
- School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan.
- School of Public Health, National Defense Medical Center, Taipei 114, Taiwan.
- Department of Ophthalmology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.
- National Defense Medical Center, Graduate Institute of Medical Sciences, Taipei 114, Taiwan.
- Department of Family Medicine, Taichung Armed Forces General Hospital, Taichung 411, Taiwan.
ORCID-Profile: Sheng-Yin To, Li-Ting Kao
Zitieren
APA
To, S. Y., Lin, H. T., Liao, C. C., Pan, K. T., Wen, Y. L., Kao, S., & Kao, L. T. (2024). Association between amiodarone use and risk of cataract: a population-based active-comparator study. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgae034
Vancouver
To SY, Lin HT, Liao CC, Pan KT, Wen YL, Kao S, et al. Association between amiodarone use and risk of cataract: a population-based active-comparator study. Postgraduate Medical Journal. 2024. doi:10.1093/postmj/qgae034
BibTeX
@article{To2024,
author = {To, Sheng-Yin and Lin, Hsin-Ting and Liao, Chun-Cheng and Pan, Ke-Ting and Wen, Yuan-Liang and Kao, Senyeong and Kao, Li-Ting},
title = {Association between amiodarone use and risk of cataract: a population-based active-comparator study},
journal = {Postgraduate Medical Journal},
year = {2024},
doi = {10.1093/postmj/qgae034}
}
EUVIMED